Get startedLog in
    Picture of Forward Pharma A/S logo

    FWPAY — Forward Pharma A/S Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Forward Pharma A/S, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2017
    December 31st
    2018
    December 31st
    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F20-F20-F20-F20-F
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,2500000
    Cost of Revenue
    Gross Profit1,22500——
    Selling / General / Administrative Expenses
    Research And Development
    Total Operating Expenses62.612.35.283.393.87
    Operating Profit1,187-12.3-5.28-3.39-3.87
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes1,184-8.93-4.22-6.45-1.89
    Provision for Income Taxes
    Net Income After Taxes917-8.72-4.22-6.45-1.89
    Net Income Before Extraordinary Items
    Net Income917-8.72-4.22-6.45-1.89
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income917-8.72-4.22-6.45-1.89
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS4,598-184-88.8-19.2-5.53